Journal of General Virology, Vol 80, 1627-1634, Copyright © 1999 by Society for General Microbiology

ARTICLES

Cell-mediated immune responses in cattle vaccinated with a vaccinia virus recombinant expressing the nucleocapsid protein of rinderpest virus

K Ohishi, K Inui, K Yamanouchi and T Barrett
Institute for Animal Health, Pirbright Laboratory, Woking, Surrey GU24 0NF, UK

Rinderpest virus (RPV) is a member of the genus Morbillivirus in the family Paramyxoviridae which causes an acute and often fatal disease in large ruminants. To examine the immune response to the virus nucleocapsid (N) protein, a recombinant vaccinia virus expressing RPV nucleocapsid protein (rVV-RPV-N) was used to vaccinate cattle. The recombinant vaccine induced low levels of non-neutralizing anti-N antibodies. RPV-specific cell-mediated immunity induced by the recombinant was assessed by measuring both the lymphocyte proliferation and cytotoxic T-lymphocyte responses. The protective immune response was examined by challenging the vaccinated cattle with either a highly virulent (Saudi 1/81) or a mild (Kenya/eland/96) strain of the virus. The vaccinated cattle were not protected against challenge with the virulent RPV strain, except they showed a slight delay in the onset of disease when compared with the unvaccinated controls. In cattle challenged with the mild strain, apart from a transient fever, no clinical signs of rinderpest infection were seen in the vaccinated cattle. One out of two control cattle showed a similar response but the other died from classic rinderpest disease. Virus-neutralizing antibodies were induced more quickly following challenge with the mild strain in vaccinated cattle compared to the control animals. These data suggested that the cell-mediated immunity induced by rVV-RPV-N could stimulate the rapid production of neutralizing antibodies following RPV challenge but this response was not sufficient to protect against challenge with a virulent strain of the virus. Protection was seen in one of three animals challenged with a mild strain of the virus; however, a greater number of animals would need to be tested to estimate the significance of the protection afforded by the N protein.

This article has been cited by other articles:

				S. Parida, M. Mahapatra, S. Kumar, S. C. Das, M. D. Baron, J. Anderson, and T. Barrett Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine J. Gen. Virol., July 1, 2007; 88(7): 2019 - 2027. [Abstract] [Full Text] [PDF]

				M. D. Baron, A. C. Banyard, S. Parida, and T. Barrett The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes J. Gen. Virol., April 1, 2005; 86(4): 1093 - 1101. [Abstract] [Full Text] [PDF]

				J. Castillo-Olivares, J. P. Tearle, F. Montesso, D. Westcott, J. H. Kydd, N. J. Davis-Poynter, and D. Hannant Detection of equine arteritis virus (EAV)-specific cytotoxic CD8+ T lymphocyte precursors from EAV-infected ponies J. Gen. Virol., October 1, 2003; 84(10): 2745 - 2753. [Abstract] [Full Text] [PDF]

				S. C. Das, M. D. Baron, and T. Barrett Recovery and Characterization of a Chimeric Rinderpest Virus with the Glycoproteins of Peste-des-Petits-Ruminants Virus: Homologous F and H Proteins Are Required for Virus Viability J. Virol., October 1, 2000; 74(19): 9039 - 9047. [Abstract] [Full Text]

				B. T. Lund, A. Tiwari, S. Galbraith, M. D. Baron, W. I. Morrison, and T. Barrett Vaccination of cattle with attenuated rinderpest virus stimulates CD4+ T cell responses with broad viral antigen specificity J. Gen. Virol., September 1, 2000; 81(9): 2137 - 2146. [Abstract] [Full Text]

				K. Ohishi, K. Inui, T. Barrett, and K. Yamanouchi Long-term protective immunity to rinderpest in cattle following a single vaccination with a recombinant vaccinia virus expressing the virus haemagglutinin protein J. Gen. Virol., June 1, 2000; 81(6): 1439 - 1446. [Abstract] [Full Text]

				B. Schlereth, P.-G. Germann,, V. ter Meulen, and S. Niewiesk DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection J. Gen. Virol., May 1, 2000; 81(5): 1321 - 1325. [Abstract] [Full Text]